Diabetes management can pose significant challenges, particularly in finding a healthcare provider well-versed in the latest diabetes technology. This can be especially difficult for those residing outside major urban areas. However, a recent study has indicated that individuals with diabetes can reap benefits from utilizing an automated insulin delivery (AID) system, regardless of the type of healthcare provider they consult and whether the care is provided in-person or remotely.
The University of Colorado School of Medicine undertook a small-scale feasibility study involving 40 adults with type 1 diabetes to assess the effectiveness of employing the iLet Bionic Pancreas AID system with the Dexcom G6. The participants were divided into two groups: one group received care from a family physician while the other group consulted an endocrinologist. Surprisingly, the study revealed that individuals using the AID system experienced enhanced glucose levels and time within the target range, irrespective of the type of provider they consulted or the mode of care delivery.
The study’s results demonstrated a decrease in average glucose levels by 17 mg/dL, along with an 11% increase in time spent within the target glucose range for all participants using the AID system. This improvement was consistent across all groups, including those newly acquainted with AID technology. These findings indicate that primary care physicians are adept at introducing patients to AID systems, even during virtual visits, and that telehealth can be just as beneficial as in-person appointments for diabetes care.
Dr. Sean Oser, a family medicine professor at the University of Colorado, underscored the significance of these findings, noting that there was no discernible difference between the outcomes of care provided by endocrinologists and primary care physicians. Furthermore, the study also revealed no significant difference in results between participants who had in-person appointments and those who had telehealth visits. These findings are particularly relevant for individuals who may have limited access to specialized care, such as endocrinology teams, due to geographical limitations.
Dr. Eden Miller, an endocrinologist with expertise in diabetes technology, emphasized the need for primary care physicians to take a more proactive role in diabetes treatment and technology. Given that a substantial portion of individuals with diabetes receive care from primary care providers, the study underscores the importance of equipping these professionals with the necessary knowledge and training related to continuous glucose monitoring (CGM) and AID systems for effective diabetes management.
Ultimately, the study’s results underscore the potential for AID systems to have a positive impact on diabetes management, regardless of the type of healthcare provider involved or the mode of care delivery. This emphasizes the need to standardize education and treatment plans for primary care physicians in utilizing diabetes technology from the onset of diagnosis.
The findings of the study offer valuable insights into the effectiveness of AID systems for diabetes management, particularly for individuals facing geographical or access-related challenges when seeking specialized care. This research has significant implications for the future of diabetes treatment and technology as it sets the stage for greater integration of AID systems into primary care settings, ultimately benefitting a larger population of individuals with diabetes.